A second confirmatory trial of MPC-150-IM in patients with chronic heart failure

Trial Profile

A second confirmatory trial of MPC-150-IM in patients with chronic heart failure

Recruiting
Phase of Trial: Phase III

Latest Information Update: 12 Oct 2016

At a glance

  • Drugs Rexlemestrocel-L (Primary)
  • Indications Chronic heart failure
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Oct 2016 According to a Mesoblast media release, results from this trial with data in a limited number of Japanese patients could support Japanese regulatory filings and product launch.
    • 25 Aug 2016 According to a Mesoblast media release,the company plans to assess interim analysis to assess the primary endpoint between cell-treated and control patients in the first quarter of 2017.
    • 25 Aug 2016 According to a Mesoblast media release, status changed from planning to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top